本文已被：浏览 5301次 下载 0次
中文摘要: 摘 要：缺血性脑卒中因其高发病率、致残率及死亡率，已经成为全球重大公共卫生挑战。早期精准诊断、病因分型、 疗效评估及预后预测是优化临床决策、改善患者结局的关键。近年来，实验室检测技术在缺血性脑卒中领域取得显著突破， 从传统的生化标志物到新兴的多组学技术，从单一指标到整合模型，展现出巨大的应用潜力。文章系统综述了缺血性脑卒中 相关生物标志物、基因检测、多组学整合分析及快速检测技术的最新研究进展，探讨其临床应用价值与挑战，并展望未来发 展方向，旨在为缺血性脑卒中的精准诊疗提供理论依据。
中文关键词: 关键词：缺血性脑卒中 生物标志物 实验室检测 多组学 基因检测
Abstract:Abstract:Ischemic stroke has become a major global public health challenge due to its high incidence,disability rate, and mortality.Early precise diagnosis,etiological classification,treatment efficacy assessment,and prognosis prediction are crucial for optimizing clinical decision-making and improving patient outeomes.In recent years,laboratory detection technologies have achieved significant breakthroughs in the field of ischemic stroke.From traditional biochemical markers to emerging multi- omics technologies,and from single indicators to integrated models,these advancements demonstrate tremendous application potential.The systematic review summarizes the latest research advances in biomarkers,genetic testing,multi-omics integrated analysis,and rapid detection technologies for ischemic stroke.It explores their clinical value and challenges while outlining future development directions,aiming to provide a theoretical basis for precision diagnosis and treatment of ischemic stroke.
文章编号：3202410008 中图分类号：R473.74 文献标志码：
基金项目:
| 作者 | 单位 |
| 张亮 |
| Author Name | Affiliation |
引用文本：